Is FLUT a buy, hold, or sell?
FLUT carries a valuation grade of Buy. Our discounted cash flow model produces an intrinsic range of $88–$307 — implying a +78% margin of safety at the current price of $110.79. The width of the DCF range reflects genuine uncertainty in the terminal growth rate assumption: the correct framework is a probability-weighted distribution over scenarios, not a single point estimate. See the DCF valuation framework for full methodology.
With a 12% beat rate on recent quarters, earnings predictability has been mixed. The most recent quarter delivered a 12.3% earnings surprise. Analyst estimate revisions are trending downward.
What are FLUT's key risk factors?
With a beta of 1.09, FLUT exhibits a market-neutral risk profile relative to the broad market. The 95th-percentile CVaR of -42.8% on a one-month horizon should inform position sizing directly: at a 10% portfolio weight, this tail event contributes approximately 4.3% of total portfolio loss in the worst 5% of months. Net margins of -2.2% fall below the Consumer Cyclical sector average of 10%, suggesting margin pressure. Leverage is moderate with debt-to-equity at 129%.
At 0.71, the put/call ratio skews bullish, with call buyers dominating recent flow. Implied and realized volatility are roughly aligned at 54.8% and 50.5% respectively. Insiders have been net sellers to the tune of $22.4M recently. While routine dispositions are common, the magnitude bears watching. Short interest of 10.3% of float is elevated, reflecting meaningful bearish positioning.
How does FLUT fit in a diversified portfolio?
At typical HENRY portfolio weights — 10–20% of the equity allocation — FLUT carries a beta of 1.09, meaning it amplifies broad market moves proportionally. The appropriate weight is not a function of conviction alone, but of the full covariance structure across all holdings. See the Ledoit-Wolf covariance framework for the methodology behind these calculations.
Among closely correlated names, FLUT shows the strongest co-movement with DKNG (0.69), BKNG (0.34), ABNB (0.28). Investors seeking diversification should note these correlation dynamics when constructing multi-asset portfolios.
True portfolio risk is a function of the full covariance structure across all holdings — not individual stock metrics. The Portfolio Health Check quantifies this at the portfolio level: it surfaces hidden concentration, marginal CVaR contributions, and the degree to which your overall allocation deviates from an optimal risk-adjusted mandate. The FLUT analysis here is a single node in that larger structure.
For the portfolio construction framework underpinning FLUT’s position sizing and conviction rating — including IPS guardrails, Black-Litterman allocation, and CVaR constraints — see: Investment Policy Statement Framework →
